Skip to content
Syenza News
  • Home
  • Topics
    • Artificial intelligence and machine learning
    • Cost-Effectiveness Analysis
    • Infectious diseases
    • Health Equity and Access to Care
    • HTA
    • Oncology Research
  • Region
    • Europe
    • North America
    • Sub-Saharan Africa
  • Events
  • About
  • Visit Syenza
BACK TO MAIN SITE

Health Economic Assessment of Nirsevimab for Re...

By Charmi Patel

July 23, 2024

Introduction
Biosimilars in Juvenile Arthritis Management: Connecting the Treatment Continuum
Forecasting Innovations in Cutaneous Malignant Melanoma Treatment in Sweden
Addressing Valvular Heart Disease in Saudi Arabia
Game-Changer in Atopic Dermatitis Care: Abrocitinib’s Cost-Effectivenes...
Transferability of AI Methods for Diabetes Modelling in Health Technology Ass...
Best Practices for Preventing Statistical Pitfalls in Observational Research
Tuberculosis Care in Indonesia: A Financial Analysis of Strategic Purchasing ...
Cost Savings on Generic Drugs: Transparent Pricing Models
Introducing GRACE for Patient-Centric Care
Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor
Making Better Choices in Diabetes Care With Multi-criteria Decision Making (M...
The Power of Real-World Evidence: Bringing Everyday Health Data to Drug Appro...
« Previous 1 … 3 4 5 6 7 … 11 Next »

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.
PARTNER WITH US
schedule a meeting

SPEAK WITH US

+1 617 219 9400

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

WRITE US

[email protected]

JOIN NEWSLETTER

This is required.
This is required.
This is required.

SERVICES

  • HEOR
  • Global Market Access
  • Dynamic Intelligence
  • Glossary of Terms
  • Advanced Degrees

QUICK LINKS

  • About
  • Case Studies
  • Insights
  • Art of Science
  • Careers
  • Contact Us
  • Copyright Notice
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
schedule a meeting
LINKEDIN
TWITTER

Disclaimer: Syenza News is an educational and informational platform. Content does not constitute clinical, medical, or professional healthcare advice.

© 2026 Syenza™. All rights reserved.

Made with heart by Frogiez

schedule a meeting
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}